Clinical Trials Browser

Recurrence × Sorafenib × Lymphoid × Clear all

Blast Crisis, Recurrence, Leukemia, Myelogenous, Chronic, BCR-ABL Positive, Precursor Cell Lymphoblastic Leukemia-Lymphoma, Leukemia, Myelomonocytic, Juvenile

NCT01561833 2020-08-13

A Pilot Study of Sorafenib Examining Biomarkers in Refractory or Relapsed T-Cell Lymphoma Patients

Phase 1 Completed

12 enrolled 4 charts

Lymphoid

Recurrence, Lymphoma, T-Cell

Clinical Trials

Sorafenib in Treating Young Patients With Relapsed or Refractory Solid Tumors or Leukemia

A Pilot Study of Sorafenib Examining Biomarkers in Refractory or Relapsed T-Cell Lymphoma Patients